Liaison(s): Pratik Ahuja, Leslie Maurer, Ceylan Undey
Founded in 1983, Amgen is one of the largest independent biotechnology companies in the world. The company’s primary goal is to serve patients by focusing on diseases with high unmet medical needs. Currently, Amgen has 11 sites and more than 40 contract sites around the world to supply demand for 21 marketed products.
The goal of this year’s TMP project is to create a model to forecast demand and required capacity for Amgen’s drug substance and drug product facilities. The team will be focusing on creating an Excel model based on Amgen’s current state of Thousand Oaks’, Massachusetts’, and Rhode Island’s capacity thresholds while forecasting clinical and commercial demand requirements for these plants.